Jan Hillson

Jan Hillson

Direktor/Vorstandsmitglied bei ELEDON PHARMACEUTICALS, INC.

Vermögen: - $ am 31.08.2026

73 Jahre
Health Technology
Consumer Services
Health Services

Profil

Jan L.
Hillson
is currently an Independent Director at Eledon Pharmaceuticals, Inc. since 2021 and a Partner at Cascadia Drug Development Group LLC starting in 2024.
Former roles include Senior Vice President-Clinical Development at Provention Bio, Inc. from 2021 to 2024, Senior Vice President-Clinical Development at Alpine Immune Sciences, Inc. from 2019 to 2021, Senior Vice President-Drug Development at ChemoCentryx, Inc. from 2016 to 2019, Vice President-Clinical & Translational Research at Momenta Pharmaceuticals, Inc. from 2013 to 2016, Senior Director at ZymoGenetics, Inc. from 2007 to 2013, Medical Director at Xcyte Therapies, Inc., Assistant Professor at the University of Washington, Division Head at Virginia Mason Medical Center, Chief Medical Officer at GlycoEra AG, and Member-Clinical Faculty at Harvard Medical School.
Education includes undergraduate studies at Michigan State University, graduate degrees from California Institute of Technology and Scripps Institution of Oceanography, and a doctorate from Stanford University School of Medicine.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
31.03.2026 0 ( -.--% ) - $ 31.08.2026

Aktive Positionen von Jan Hillson

UnternehmenPositionBeginn
ELEDON PHARMACEUTICALS, INC. Direktor/Vorstandsmitglied 02.07.2021
Corporate Officer/Principal 01.02.2024

Ehemalige bekannte Positionen von Jan Hillson

UnternehmenPositionEnde
PROVENTION BIO, INC. Corporate Officer/Principal 01.02.2024
ALPINE IMMUNE SCIENCES, INC. Technik-/Wissenschafts-/F&E-Leiter 01.11.2021
CHEMOCENTRYX, INC. Corporate Officer/Principal 01.06.2019
MOMENTA PHARMACEUTICALS, INC. Technik-/Wissenschafts-/F&E-Leiter 01.01.2016
Corporate Officer/Principal 01.01.2013
Sehen Sie sich die Erfahrung von Jan Hillson im Detail an

Ausbildung von Jan Hillson

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

67

Beziehungen ersten Grades

16

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen16

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Services

Consumer Services

Consumer Services

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

  1. Börse
  2. Insiders
  3. Jan Hillson
-40 %: Exklusive Verlängerung
T
:
:
PROFITIEREN SIE JETZT